SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       PURSUANT TO SECTION 13 OR 15(D) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

       Date of Report (Date of earliest event reported): February 4, 2006

                            BANKFINANCIAL CORPORATION
                            -------------------------
               (Exact Name of Registrant as Specified in Charter)

         Maryland                       0-51331                  75-3199276
- -----------------------------     ---------------------      -------------------
(State or Other Jurisdiction)     (Commission File No.)       (I.R.S. Employer
      of Incorporation)                                      Identification No.)


15W060 North Frontage Road, Burr Ridge, Illinois                   60527
- ------------------------------------------------                 ----------
(Address of Principal Executive Offices)                         (Zip Code)

Registrant's telephone number, including area code:  (630) 242-7700
                                                     --------------



                                 Not Applicable
                                 --------------
          (Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ]  Written communications  pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17
     CFR 240.14a-12)

[ ]  Pre-commencement  communications  pursuant  to Rule  14d-2(b)  under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement  communications  pursuant  to Rule  13e-4(c)  under the
     Exchange Act (17 CFR 240.13e-4(c))








Item 8.01.      Other Events.

     On  February  4, 2006,  Dr.  Kenneth  Cmiel,  a Director  of  BankFinancial
Corporation  (the  "Company") and its  wholly-owned  subsidiary,  BankFinancial,
F.S.B.  (the  "Bank"),  passed  away  unexpectedly  as a result of a  previously
undetected  brain  tumor.  Dr. Cmiel served as a Director of the Bank since 1989
and as a member of its Asset Liability Management  Committee,  a Director of the
Company since its formation in 2004, and a Director of the Company's predecessor
federal corporations from 1999 to 2005. Dr. Cmiel was a Professor of History and
American  Studies at the  University of Iowa, and the Director of the University
of Iowa Center for Human Rights.

Item 9.01.      Financial Statements and Exhibits.

     None.








                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, hereunto duly authorized.

                                            BANKFINANCIAL CORPORATION



Date: February 9, 2006                 By:  /s/ James J. Brennan
                                            ------------------------------------
                                            James J. Brennan
                                            Executive Vice President and
                                             Corporate Secretary